WallStreetZenWallStreetZen

NASDAQ: SPEC
Spectaire Holdings Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for SPEC

Based on 1 analyst offering 12 month price targets for Spectaire Holdings Inc.
Min Forecast
$2.50+285.21%
Avg Forecast
$2.50+285.21%
Max Forecast
$2.50+285.21%

Should I buy or sell SPEC stock?

Based on 1 analyst offering ratings for Spectaire Holdings Inc.
Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SPEC stock forecasts and price targets.

SPEC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-15

1 of 1

Forecast return on equity

Is SPEC forecast to generate an efficient return?

Forecast return on assets

Is SPEC forecast to generate an efficient return on assets?

SPEC revenue forecast

What is SPEC's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$26.0M
Avg 2 year Forecast
$43.4M

SPEC vs Pollution & Treatment Control Stocks

TickerPricePrice TargetUp/downsideConsensus
SPEC$0.65$2.50+285.21%Hold
CHNR$0.96N/AN/A
TOMZ$0.61$3.50+477.56%Buy
CLWT$1.56N/AN/A
LIQT$2.63$5.15+95.82%Buy
View Top Pollution & Treatment Control Stocks

Spectaire Holdings Stock Forecast FAQ

Is Spectaire Holdings Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: SPEC) stock is to Hold SPEC stock.

Out of 1 analyst, 0 (0%) are recommending SPEC as a Strong Buy, 0 (0%) are recommending SPEC as a Buy, 1 (100%) are recommending SPEC as a Hold, 0 (0%) are recommending SPEC as a Sell, and 0 (0%) are recommending SPEC as a Strong Sell.

If you're new to stock investing, here's how to buy Spectaire Holdings stock.

What is SPEC's revenue growth forecast for 2024-2025?

(NASDAQ: SPEC) Spectaire Holdings's forecast annual revenue growth rate of N/A is not forecast to beat the US Pollution & Treatment Controls industry's average forecast revenue growth rate of 6.5%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.93%.

Spectaire Holdings's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast SPEC's revenue for 2024 to be $398,966,464, with the lowest SPEC revenue forecast at $398,966,464, and the highest SPEC revenue forecast at $398,966,464.

In 2025, SPEC is forecast to generate $665,967,098 in revenue, with the lowest revenue forecast at $665,967,098 and the highest revenue forecast at $665,967,098.

What is SPEC's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: SPEC) forecast ROA is N/A, which is lower than the forecast US Pollution & Treatment Controls industry average of 4.35%.

What is SPEC's Price Target?

According to 1 Wall Street analyst that have issued a 1 year SPEC price target, the average SPEC price target is $2.50, with the highest SPEC stock price forecast at $2.50 and the lowest SPEC stock price forecast at $2.50.

The Wall Street analyst predicted that Spectaire Holdings's share price could reach $2.50 by Nov 15, 2024. The average Spectaire Holdings stock price prediction forecasts a potential upside of 285.21% from the current SPEC share price of $0.65.

What is SPEC's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: SPEC) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.